Novo Nordisk Shares Tumble 8% on CagriSema Weight Loss Miss – GuruFocus.com

Novo Nordisk Shares Tumble 8% on CagriSema Weight Loss Miss  GuruFocus.com

Judge Denies Injunction for Copycats of Lilly’s Weight Loss Drug – Bloomberg Law

Judge Denies Injunction for Copycats of Lilly’s Weight Loss Drug  Bloomberg Law

Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss – MedCity News

Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss  MedCity News

Former Weight Loss Spokesman Suing Doctor He Says Over-Prescribed Ozempic Type Drugs, Caused Him Severe Injuries – Showbiz411

Former Weight Loss Spokesman Suing Doctor He Says Over-Prescribed Ozempic Type Drugs, Caused Him Severe Injuries  Showbiz411

Lilly sees launching weight loss drugs in China, India starting late 2025 – Seeking Alpha

Lilly sees launching weight loss drugs in China, India starting late 2025  Seeking Alpha

The State of Weight Loss Drugs – The Motley Fool

The State of Weight Loss Drugs  The Motley Fool

The State of Weight Loss Drugs – The Motley Fool

The State of Weight Loss Drugs  The Motley Fool

Novo’s Wegovy successor disappoints in second large trial – BioPharma Dive

Novo’s Wegovy successor disappoints in second large trial  BioPharma Dive

Novo Nordisk shares fall on weight-loss drug trial – MSN

Novo Nordisk shares fall on weight-loss drug trial  MSN

Sugar reduction and GLP-1s – Food Business News

Sugar reduction and GLP-1s  Food Business News